agilon health Sets Date to Report First Quarter 2024 Financial Results...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: May 18, 2024

Avangrid to Be Acquired by Iberdrola • Upneeq® Wins 2024 Shape Skin Award, “Best for Lift”, in the Professional Treatment Category • Sacred Heart Celebrates 125th Anniversary • The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024 • HERImpact: Entrepreneurship for Impact Program Kicks Off in Chicago, Empowering Women Entrepreneurs • Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer • Historic Inaugural Class Graduates from OSU College of Osteopathic Medicine at the Cherokee Nation • Dillard’s, Inc. Announces $0.25 Cash Dividend • Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08 • Angels Helpers NYC 2024 Charity Gala Raises Funds for Harlem School of the Arts, Highbridge Voices • After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) • Historic Bellevue House reopens • Rockwell Institute Celebrates Highest Real Estate Exam Pass Rates for First-Time Test Takers in the State of Washington • L.A. Care and Blue Shield of California Promise Health Plans Unveil New, Vibrant Community Resource Center in Panorama City with • Statement by the Prime Minister on Tamil Genocide Remembrance Day • May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans • Federal, provincial and territorial ministers gather to support culture and heritage at annual meeting • Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share • Aramco and Spiritus to Advance Direct Air Capture Technology, Investment by Aramco Ventures • WOMEN'S HEALTHCARE COMPANY WATKINS-CONTI RECEIVES FDA 510(K) CLEARANCE FOR NEW STRESS URINARY INCONTINENCE DEVICE YŌNI.FIT&

www.blackradionetwork.com > agilon health Sets Date to Report First Quarter 2024 Financial Results

agilon health Sets Date to Report First Quarter 2024 Financial Results

AUSTIN, Texas , April 16 /Businesswire/ - agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the first quarter 2024 after the market closes on Tuesday, May 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results.

The conference call can be accessed by dialing (833) 470-1428 for U.S. participants and +1 (929) 526-1599 for international participants and referencing participant code 690899. A simultaneous webcast can be accessed by visiting the “Events & Presentations” section of agilon’s Investor Relations website at https://investors.agilonhealth.com. A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call.

About agilon health

agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups and health systems transition to a value-based Total Care Model for their senior patients. agilon provides the technology, people, capital, process, and access to a peer network of 2,400+ PCPs that allow its physician partners to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 30+ diverse communities and is here to help more of our nation's leading physician groups and health systems have a sustained, thriving future. For more information visit www.agilonhealth.com and connect with us on Instagram, LinkedIn and YouTube.